Despina Thomaidou
-
- Renal cell carcinoma treatment 15
- Lung Cancer Treatments and Mutations 7
-
- Cancer Immunotherapy and Biomarkers 5
- Lung Cancer Research Studies 5
- Pancreatic and Hepatic Oncology Research 3
-
- Cancer Genomics and Diagnostics 7
-
- Renal and related cancers 7
-
- Economic and Financial Impacts of Cancer 6
- Co-authors
- K. Eszter BorbasTodd M. BauerAnna PolliSotiris MissailidisGeoffrey LiuEnriqueta FelipJulien MazièresAlice T. Shaw
- Partner nations
- United StatesItalyFrance
In The Last Decade
Despina Thomaidou
22 papers receiving 273 citations
Hit Papers
Peers
Comparison fields: 5 of 46
- Pulmonary and Respiratory Medicine 214
- Oncology 142
- Cancer Research 60
- Molecular Biology 123
- Pathology and Forensic Medicine 18
Countries citing papers authored by Despina Thomaidou
This map shows the geographic impact of Despina Thomaidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Despina Thomaidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Despina Thomaidou more than expected).
Fields of papers citing papers by Despina Thomaidou
This network shows the impact of papers produced by Despina Thomaidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Despina Thomaidou. The network helps show where Despina Thomaidou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Despina Thomaidou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Studybreakdown → | 2024 | 118 |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 11 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 10 | |
| 11 | 2022 | 2 | |
| 12 | 2021 | 13 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 1 | |
| 15 | 2021 | 4 | |
| 16 | 2020 | 5 | |
| 17 | 2019 | 16 | |
| 18 | 2019 | 6 | |
| 19 | 2018 | 20 | |
| 20 | 2004 | 30 |
About Despina Thomaidou
Despina Thomaidou is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 23 papers that have together received 276 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (15 papers), Renal and related cancers (7 papers), Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (7 papers), Economic and Financial Impacts of Cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Research Studies (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (214 citations), Oncology (142 citations) and Cancer Research (60 citations). Despina Thomaidou has collaborated with scholars based in United States, Italy and France. Frequent co-authors include K. Eszter Borbas, Todd M. Bauer, Anna Polli, Sotiris Missailidis, Geoffrey Liu, Enriqueta Felip, Julien Mazières, Alice T. Shaw, Rossella Messina and Tony Mok. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Lung Cancer, Future Oncology and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.